These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 22055718)
1. Structure-activity relationships of chalcone analogs as potential inhibitors of ADP- and collagen-induced platelet aggregation. Vijaya Bhaskar Reddy M; Tsai WJ; Qian K; Lee KH; Wu TS Bioorg Med Chem; 2011 Dec; 19(24):7711-9. PubMed ID: 22055718 [TBL] [Abstract][Full Text] [Related]
2. Synthesis and evaluation of antiplatelet activity of trihydroxychalcone derivatives. Zhao LM; Jin HS; Sun LP; Piao HR; Quan ZS Bioorg Med Chem Lett; 2005 Nov; 15(22):5027-9. PubMed ID: 16169724 [TBL] [Abstract][Full Text] [Related]
3. Structure-activity relationship studies on chalcone derivatives: potent inhibition of platelet aggregation. Ko HH; Hsieh HK; Liu CT; Lin HC; Teng CM; Lin CN J Pharm Pharmacol; 2004 Oct; 56(10):1333-7. PubMed ID: 15482650 [TBL] [Abstract][Full Text] [Related]
5. 2'-Ethoxy-5'-methoxy-2-(5-methylthienyl)chalcone inhibits collagen-induced protein tyrosine phosphorylation and thromboxane formation during platelet aggregation and adhesion. Lo HM; Huang TF; Lin CN; Peng HC; Wu WB Pharmacology; 2009; 84(3):145-52. PubMed ID: 19690443 [TBL] [Abstract][Full Text] [Related]
6. Inhibitory effect of hericenone B from Hericium erinaceus on collagen-induced platelet aggregation. Mori K; Kikuchi H; Obara Y; Iwashita M; Azumi Y; Kinugasa S; Inatomi S; Oshima Y; Nakahata N Phytomedicine; 2010 Dec; 17(14):1082-5. PubMed ID: 20637576 [TBL] [Abstract][Full Text] [Related]
7. Stereoselective inhibition of human platelet aggregation by R-138727, the active metabolite of CS-747 (prasugrel, LY640315), a novel P2Y12 receptor inhibitor. Hasegawa M; Sugidachi A; Ogawa T; Isobe T; Jakubowski JA; Asai F Thromb Haemost; 2005 Sep; 94(3):593-8. PubMed ID: 16268477 [TBL] [Abstract][Full Text] [Related]
8. A new insight of anti-platelet effects of sirtinol in platelets aggregation via cyclic AMP phosphodiesterase. Liu FC; Liao CH; Chang YW; Liou JT; Day YJ Biochem Pharmacol; 2009 Apr; 77(8):1364-73. PubMed ID: 19426675 [TBL] [Abstract][Full Text] [Related]
9. Antiplatelet activity of carnosol is mediated by the inhibition of TXA2 receptor and cytosolic calcium mobilization. Lee JJ; Jin YR; Lim Y; Hong JT; Kim TJ; Chung JH; Yun YP Vascul Pharmacol; 2006 Sep; 45(3):148-53. PubMed ID: 16916624 [TBL] [Abstract][Full Text] [Related]
11. The protective effects of paclitaxel on platelet aggregation through the inhibition of thromboxane A2 synthase. Lee JJ; Yu JY; Lee JH; Zhang WY; Kim TJ; Myung CS; Yun YP Arch Pharm Res; 2010 Mar; 33(3):387-94. PubMed ID: 20361303 [TBL] [Abstract][Full Text] [Related]
12. Effect of isoquinoline alkaloids of different structural types on antiplatelet aggregation in vitro. Chia YC; Chang FR; Wu CC; Teng CM; Chen KS; Wu YC Planta Med; 2006 Oct; 72(13):1238-41. PubMed ID: 16981134 [TBL] [Abstract][Full Text] [Related]
13. Synthesis and pharmacological evaluation of novel beta-nitrostyrene derivatives as tyrosine kinase inhibitors with potent antiplatelet activity. Wang WY; Hsieh PW; Wu YC; Wu CC Biochem Pharmacol; 2007 Aug; 74(4):601-11. PubMed ID: 17601492 [TBL] [Abstract][Full Text] [Related]
14. Bioassay-guided isolation and identification of anti-platelet-active compounds from the root of Ashitaba (Angelica keiskei Koidz.). Son DJ; Park YO; Yu C; Lee SE; Park YH Nat Prod Res; 2014; 28(24):2312-6. PubMed ID: 25019280 [TBL] [Abstract][Full Text] [Related]
15. Antiplatelet activity of carnosic acid, a phenolic diterpene from Rosmarinus officinalis. Lee JJ; Jin YR; Lee JH; Yu JY; Han XH; Oh KW; Hong JT; Kim TJ; Yun YP Planta Med; 2007 Feb; 73(2):121-7. PubMed ID: 17410649 [TBL] [Abstract][Full Text] [Related]
16. Synthesis and anti-platelet activity of obovatol derivatives. Kwak JH; Lee S; Park ES; In JK; Song J; Kim YJ; Choi NS; Lee H; Yun YP; Hong JT; Kwak YS; Min KH; Jung JK Arch Pharm Res; 2011 Jul; 34(7):1107-12. PubMed ID: 21811917 [TBL] [Abstract][Full Text] [Related]
17. Synthesis and evaluation of platelet aggregation inhibitory activity of some 3-phenyl-pyrroloquinazolinones. Ferlin MG; Borgo C; Deana R Eur J Med Chem; 2012 Feb; 48():275-83. PubMed ID: 22236469 [TBL] [Abstract][Full Text] [Related]
18. 2',5'-Dihydroxychalcone as a potent chemical mediator and cyclooxygenase inhibitor. Lin CN; Lee TH; Hsu MF; Wang JP; Ko FN; Teng CM J Pharm Pharmacol; 1997 May; 49(5):530-6. PubMed ID: 9178190 [TBL] [Abstract][Full Text] [Related]
19. Synthesis and in vitro inhibitory activity on human platelet aggregation of novel properly substituted 4-(1-piperazinyl)coumarins. Di Braccio M; Grossi G; Roma G; Grazia Signorello M; Leoncini G Eur J Med Chem; 2004 May; 39(5):397-409. PubMed ID: 15110966 [TBL] [Abstract][Full Text] [Related]
20. THE SEARCH OF COMPOUNDS WITH ANTIAGGREGATION ACTIVITY AMONG S-ESTERS OF THIOSULFONIC ACIDS. Halenova TI; Nikolaeva IV; Nakonechna AV; Bolibrukh KB; Monka NY; Lubenets VI; Savchuk OM; Novikov VP; Ostapchenko LI Ukr Biochem J; 2015; 87(5):83-92. PubMed ID: 26717599 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]